| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — |
| Gross Profit | — | — | — | — | — |
| R&D Expense | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — |
| Operating Income | $3.1B | $2.4B | $3.6B | $5.6B | $2.9B |
| Net Income | $1.4B | $1.1B | $3.2B | $4.1B | $1.3B |
| EPS (Basic) | $3.99 | $2.28 | $9.26 | $11.05 | $2.60 |
| EPS (Diluted) | $3.99 | $2.27 | $9.25 | $11.02 | $2.59 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ |
|---|---|---|---|---|---|
| Total Assets | $17.8B | $19.4B | $15.2B | $13.1B | $13.3B |
| Current Assets | $2.1B | $3.4B | $2.5B | $2.7B | $2.4B |
| Cash & Equivalents | $0.5B | $0.6B | $0.1B | $0.2B | $0.3B |
| Total Liabilities | — | — | — | — | — |
| Current Liabilities | $2.6B | $3.0B | $2.4B | $2.9B | $2.1B |
| Stockholders' Equity | $6.1B | $5.3B | $2.7B | $0.4B | $-1.6B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ |
|---|---|---|---|---|---|
| Operating Cash Flow | $4.5B | $3.6B | $3.1B | $4.9B | $3.5B |
| Investing Cash Flow | $-2.2B | $-0.9B | $-2.1B | $-1.5B | $-0.8B |
| Capital Expenditures | — | — | — | — | — |
| Financing Cash Flow | $-2.5B | $-2.2B | $-1.1B | $-3.5B | $-2.6B |